Physician

Matthew Brian Donovan, MD

According to 2025 Medicare claims, Matthew Donovan, MD (NPI: 1366804858) practices ophthalmology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34452-4803.

Donovan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,265 traditional Medicare patients, billed 37,080 HCPCS/CPT codes, and received $1,384,485 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 490 prescription claims across 140 beneficiaries totaling $40,800 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 12 records totaling $369. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $531 to $1,384,485. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,942 to $40,800. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$692K$1.4M2020 Medicare payment: $531 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,695 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $746,339 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,029,828 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,384,485 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201111$531
20212835$5,695
20227085,279$746,339
20231,09217,562$1,029,828
20241,26537,080$1,384,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$48K$96K2016 Drug cost: $2,942 (USD; Tot_Drug_Cst)2017 Drug cost: $2,446 (USD; Tot_Drug_Cst)2018 Drug cost: $9,875 (USD; Tot_Drug_Cst)2019 Drug cost: $27,911 (USD; Tot_Drug_Cst)2020 Drug cost: $51,499 (USD; Tot_Drug_Cst)2021 Drug cost: $15,460 (USD; Tot_Drug_Cst)2022 Drug cost: $65,245 (USD; Tot_Drug_Cst)2023 Drug cost: $95,780 (USD; Tot_Drug_Cst)2024 Drug cost: $40,800 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162349$2,942
20174084$2,446
201821125$9,875
201953249$27,911
202059393$51,499
20214899$15,460
202287249$65,245
2023112378$95,780
2024140490$40,800

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more787993$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more742939$72
92134Imaging of retina1,1332,038$31
92250Photography of the retina203214$28
92201Extended exam of the back part of the eye with retinal drawing203212$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost11799$6,366
Prednisolone AcetatePrednisolone Acetate1173,742$4,370
Ketorolac TromethamineKetorolac Tromethamine1132,256$2,965
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat563,301$911
LatanoprostLatanoprost633,399$670

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$369Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Brian Donovan, MD?

Tedicare shows public-source Medicare data for Matthew Brian Donovan, MD (NPI 1366804858), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Brian Donovan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Brian Donovan, MD?

Matthew Brian Donovan, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Matthew Brian Donovan, MD have Open Payments data?

Matthew Brian Donovan, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.